Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.44 |
| ▸ | HNF4A | P41235 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | FABP3 | P05413 | 1/20 | 0.40 |
| ▸ | FABP4 | P15090 | 1/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13964794 | 0.85 | BCAT2 (0.43) | BCAT2MEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL6962967 | 0.84 | BCAT2 (0.46) | BCAT2MEN1KMT2ASMN1; SMN2TSHR | |
| SCHEMBL28613771 | 0.84 | BCAT2 (0.50) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| SCHEMBL8343625 | 0.84 | SLC6A4 (0.53) | BCAT2MEN1KMT2AALDH1A1GAA | |
| SCHEMBL7899207 | 0.82 | BCAT2 (0.44) | BCAT2CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL6070294 | 0.81 | BCAT2 (0.56) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| SCHEMBL7897892 | 0.81 | TAAR1 (0.48) | BCAT2DPP4 | |
| SCHEMBL7896378 | 0.81 | BCAT2 (0.43) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| Hydrochlorthiazide SCHEMBL5946143 | 0.80 | BCAT2 (0.44) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| SCHEMBL7889274 | 0.79 | BCAT2 (0.42) | BCAT2CHRNB2CHRNB4CHRNA3CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102560467-A | Highly corrosion-resistant galvanized black passivating agent and preparation method thereof | JINAN DILIGENCE TECHNOLOGY CO LTD | 2012-07-11 | — | — | CN | claimed |
| CN-105492179-B | The composition and the product made of the elastomer film for forming elastomer film | 皮肤防护有限公司 | 2019-03-08 | — | — | CN | disclosed |
| CN-105531092-B | Form the composition of elastomer film and the product made of the elastomer film | 皮肤防护有限公司 | 2018-04-20 | — | — | CN | disclosed |
| US-9801861-B2 | Antimicrobial substituted thiazoles and methods of use | PURDUE RESEARCH FOUNDATION (US) | 2017-10-31 | — | — | US | disclosed |
| US-20160243088-A1 | ANTIMICROBIAL SUBSTITUTED THIAZOLES AND METHODS OF USE | PURDUE RESEARCH FOUNDATION (US) | 2016-08-25 | — | — | US | disclosed |
| US-9353072-B2 | Antimicrobial substituted thiazoles and methods of use | PURDUE RESEARCH FOUNDATION (US) | 2016-05-31 | — | — | US | disclosed |
| CN-105531092-A | Elastomeric film-forming compositions and articles made from the elastomeric film | SKINPROTECT CORP SDN BHD | 2016-04-27 | — | — | CN | disclosed |
| CN-105492179-A | Elastomeric film-forming compositions and articles made from the elastomeric film | SKINPROTECT CORP SDN BHD | 2016-04-13 | — | — | CN | disclosed |
| CN-103946337-A | Hygrochromic/thermochromic composition and hygrochromic/thermochromic indicator | SAKURA COLOR PROD CORP | 2014-07-23 | — | — | CN | disclosed |
| US-20140121249-A1 | ANTIMICROBIAL SUBSTITUTED THIAZOLES AND METHODS OF USE | PURDUE RESEARCH FOUNDATION | 2014-05-01 | — | — | US | disclosed |
| EP-0711762-B1 | PROCESS FOR PRODUCING TETRAZOLE COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2003-08-06 | — | — | EP | disclosed |
| US-6277998-B1 | REACTING 2-CYANO-4-OXO-4H-BENZOPYRAN COMPOUND WITH HYDROGEN SULFIDE AND THEN REACTING PROUDCT WITH ALKYL HALIDE; REACTING THE PRODUCT WITH HYDRAZINE OR ITS SALT AND THEN WITH NITROUS ACID COMPOUND TO OBTAIN TETRAZOLE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-21 | — | — | US | disclosed |
| US-6191289-B1 | REACTING A 4-OXO-4H-BENZOPYRAN GROUP SUBSTITUTED WITH AMIDE OR A PHENYL GROUP IN ITS 2 POSITION IS REACTED WITH ANHYDROUS HYDRAZINE OR SALT IN PRESENCE OF CATALYST FOLLOWED BY REACTING WITH NITROUS ACID OR SALT TO FORM TETRAZOLE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-02-20 | — | — | US | disclosed |
| US-5874593-A | SULFUR CONTAINING AMIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-02-23 | — | — | US | disclosed |
| CN-1033584-C | Benzo-fused lactams that promote release of growth hormone | MERCK & CO INC (US) | 1996-12-18 | — | — | CN | disclosed |
| EP-0711762-A1 | PROCESS FOR PRODUCING TETRAZOLE COMPOUND AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
| US-4055665-A | Treating arrythmia with phenylthioaralkylamines | MERCK & CO., INC. (US) | 1977-10-25 | — | — | US | disclosed |
| US-4018830-A | Phenylthioaralkylamines | MERCK & CO., INC. (US) | 1977-04-19 | — | — | US | disclosed |
| US-3953464-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | WARNER-LAMBERT COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3951997-A | ANTIINFLAMMATORY, ANALGESIC | WARNER-LAMBERT COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140121249-A1 | ANTIMICROBIAL SUBSTITUTED THIAZOLES AND METHODS OF USE | CLPP, ELANE, NOD2 | BCAT2 805/4885MEN1 4606/4885KMT2A 4497/4885 |
| US-20160243088-A1 | ANTIMICROBIAL SUBSTITUTED THIAZOLES AND METHODS OF USE | CLPP, ELANE, NOD2 | BCAT2 805/4885MEN1 4606/4885KMT2A 4497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.